Brink Therapeutics
Unlocking in vivo cell therapy with the next generation of gene editing technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €3.5m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads